{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T21:29:23Z","timestamp":1769290163986,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007329","name":"Universidad del Valle","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013409","name":"Colombian General System of Royalties","doi-asserted-by":"publisher","award":["BPIN 2021000100099"],"award-info":[{"award-number":["BPIN 2021000100099"]}],"id":[{"id":"10.13039\/501100013409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbrc.2026.153307","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:33:37Z","timestamp":1768689217000},"page":"153307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytotoxic and anti-metastatic effects of Pllans-II from Porthidium lansbergii lansbergii venom against prostate cancer cells"],"prefix":"10.1016","volume":"800","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-9831","authenticated-orcid":false,"given":"Cesar","family":"Vela-Prieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0783-5839","authenticated-orcid":false,"given":"Mildrey","family":"Mosquera Escudero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-4207","authenticated-orcid":false,"given":"Alejandro","family":"Montoya-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6043-1521","authenticated-orcid":false,"given":"Eli\u00e9cer","family":"Jim\u00e9nez-Charris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbrc.2026.153307_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153307_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153307_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153307_bib4","series-title":"Global Cancer Observatory: C\u00e1ncer Tomorrow","author":"Ferlay","year":"2025"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153307_bib5","first-page":"16","article-title":"Cancer incidence estimates and mortality for the top five cancers in Colombia, 2007-2011, Colomb","volume":"49","author":"Pardo","year":"2018","journal-title":"Med"},{"issue":"9","key":"10.1016\/j.bbrc.2026.153307_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153307_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000506693","article-title":"Docetaxel rechallenge in patients with metastatic prostate cancer: a comprehensive review","volume":"43","author":"Assi","year":"2020","journal-title":"Oncol. Res. Treat."},{"issue":"17","key":"10.1016\/j.bbrc.2026.153307_bib8","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153307_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/203639","article-title":"Antitumoral activity of snake venom proteins: new trends in cancer therapy","volume":"2014","author":"Calderon","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153307_bib10","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11033-024-09970-z","article-title":"Snake venom toxins as potential therapeutic agents in the treatment of prostate cancer","volume":"51","author":"Ochoa-Mosquera","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2026.153307_bib11","series-title":"Peptides in the New Millennium: Trends and Perspectives","article-title":"Snake venom peptides: promising molecules with anti-tumor effects","author":"Sarray","year":"2013"},{"issue":"28","key":"10.1016\/j.bbrc.2026.153307_bib12","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.2174\/138161210793292456","article-title":"Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from Viperidae snake venoms: biomimetic activities and potential applications","volume":"16","author":"Lomonte","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153307_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biologicals.2009.01.010","article-title":"Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region","volume":"37","author":"Gebrim","year":"2009","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153307_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/BJ20080078","article-title":"Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region","volume":"411","author":"Fujisawa","year":"2008","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153307_bib15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.peptides.2008.05.021","article-title":"Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganisms and tumor cells","volume":"29","author":"Costa","year":"2008","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153307_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.matbio.2009.03.007","article-title":"MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration","volume":"28","author":"Bazaa","year":"2009","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbrc.2026.153307_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijbiomac.2015.10.080","article-title":"Human breast cancer cell death induced by BnSP-6, a Lys-49 PLA2 homologue from Bothrops pauloensis venom","volume":"82","author":"Azevedo","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153307_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijbiomac.2019.05.164","article-title":"Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells","volume":"135","author":"Azevedo","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153307_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40409-018-0180-9","article-title":"Cytotoxic and pro-apoptotic action of MjTX-I, a phospholipase A2 isolated from Bothrops moojeni snake venom, towards leukemic cells","volume":"24","author":"Benati","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.bbrc.2026.153307_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40409-015-0044-5","article-title":"Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines","volume":"21","author":"Silva","year":"2015","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.bbrc.2026.153307_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107742","article-title":"PLA2-MjTX-II from Bothrops moojeni snake venom exhibits antimetastatic and antiangiogenic effects on human lung cancer cells","volume":"243","author":"Santos","year":"2024","journal-title":"Toxicon"},{"issue":"24","key":"10.1016\/j.bbrc.2026.153307_bib22","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3390\/cells12242812","article-title":"Exploring the safety of Pllans-II and antitumoral potential of its recombinant isoform in cervical cancer therapy","volume":"12","author":"Sevilla-S\u00e1nchez","year":"2023","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.bbrc.2026.153307_bib23","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.3390\/molecules27196491","article-title":"Pllans-II induces cell death in cervical cancer squamous epithelial cells via unfolded protein accumulation and endoplasmic reticulum stress","volume":"27","author":"Montoya-G\u00f3mez","year":"2022","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.bbrc.2026.153307_bib24","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3390\/cells12232715","article-title":"Pllans-II: unveiling the action mechanism of a promising chemotherapeutic agent targeting cervical cancer cell adhesion and survival pathways","volume":"12","author":"Montoya-G\u00f3mez","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153307_bib25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijbiomac.2018.09.053","article-title":"Antitumor potential of Pllans-II, an acidic Asp49-PLA2 from Porthidium lansbergii lansbergii snake venom on human cervical carcinoma HeLa cells\u201d","volume":"122","author":"Jim\u00e9nez-Charris","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153307_bib26","series-title":"Cell\u2013Extracellular Matrix Adhesion Assay, Epidermal Cells: Methods and Protocols","first-page":"209","author":"Varol","year":"2020"},{"key":"10.1016\/j.bbrc.2026.153307_bib27","first-page":"42","article-title":"Purification of a phospholipase A2 from Daboia russelii siamensis venom with anticancer effects","volume":"2","author":"Khunsap","year":"2011","journal-title":"J. Venom Res."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153307_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1745-7254.2007.00530.x","article-title":"Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells","volume":"28","author":"Yan","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2026.153307_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijbiomac.2019.05.164","article-title":"Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells","volume":"135","author":"de Vasconcelos Azevedo","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153307_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107742","article-title":"PLA2-MjTX-II from Bothrops moojeni snake venom exhibits antimetastatic and antiangiogenic effects on human lung cancer cells","volume":"243","author":"Santos","year":"2024","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153307_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/labinvest.2009.137","article-title":"CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venom-derived phospholipases A2, inhibit angiogenesis both in vitro and in vivo","volume":"90","author":"Kessentini-Zouari","year":"2010","journal-title":"Lab. Invest."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153307_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010124","article-title":"MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions","volume":"5","author":"Bazaa","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153307_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/toxins13050337","article-title":"Bee venom components as therapeutic tools against prostate cancer","volume":"13","author":"Badawi","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.bbrc.2026.153307_bib34","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8055","article-title":"Phospholipase A2 from krait Bungarus fasciatus venom induces human cancer cell death in vitro","volume":"7","author":"Tran","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrc.2026.153307_bib35","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.ijbiomac.2021.05.114","article-title":"Mutagenic and genotoxic activities of phospholipase A2 Bothropstoxin-I from Bothrops jararacussu in Drosophila melanogaster and human cell lines","volume":"182","author":"Naves","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153307_bib36","first-page":"148","article-title":"Snake venom, bee venom and their components exert an anti-cancer effect by triggering apoptosis and cell cycle arrest in prostate cancer","volume":"57","author":"Elrefay","year":"2019","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"key":"10.1016\/j.bbrc.2026.153307_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.toxicon.2016.07.006","article-title":"Divergent functional profiles of acidic and basic phospholipases A2 in the venom of the snake Porthidium lansbergii lansbergii","volume":"119","author":"Jim\u00e9nez-Charris","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.bbrc.2026.153307_bib38","series-title":"Toxins and Drug Discovery","first-page":"129","article-title":"Antiproliferative effects of snake venom phospholipases A2 and their perspectives for cancer treatment","author":"Osipov","year":"2017"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153307_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L","article-title":"LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis","volume":"44","author":"Thalmann","year":"2000","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.bbrc.2026.153307_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/2048","article-title":"Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells","volume":"4","author":"Nasu","year":"1998","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.bbrc.2026.153307_bib41","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1242\/jcs.00071","article-title":"Get a ligand, get a life: integrins, signaling and cell survival","volume":"115","author":"Stupack","year":"2002","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153307_bib42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/cdd.2012.156","article-title":"Caspase-8 cleaves its substrates from the plasma membrane upon CD95-induced apoptosis","volume":"20","author":"Beaudouin","year":"2013","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153307_bib43","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/cells10061522","article-title":"BECLIN1: protein structure, function and regulation","volume":"10","author":"Tran","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153307_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12253-008-9143-8","article-title":"Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1\u03b1 expression","volume":"15","author":"Chen","year":"2009","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153307_bib45","first-page":"429","article-title":"Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours","volume":"30","author":"Miracco","year":"2007","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153307_bib46","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4161\/auto.6827","article-title":"Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer","volume":"4","author":"Shen","year":"2008","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153307_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4161\/auto.5.3.7658","article-title":"Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma","volume":"5","author":"Shi","year":"2009","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153307_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2011.04.007","article-title":"Decreased Beclin-1 expression is correlated with the growth of the primary tumor in patients with squamous cell carcinoma and adenocarcinoma of the lung","volume":"43","author":"Won","year":"2012","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153307_bib49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.prp.2014.02.008","article-title":"The relation of Beclin 1 and Bcl-2 expressions in high-grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study","volume":"210","author":"Baspinar","year":"2014","journal-title":"Pathol. Res. Pract."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:19:45Z","timestamp":1769246385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0006291X26000719"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153307","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxic and anti-metastatic effects of Pllans-II from Porthidium lansbergii lansbergii venom against prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153307"}}